Drugmakers, insurers, hospitals, pharmacies, medical devices, clinical updates, and healthcare business leaders.
The company posted a second-quarter loss for the period ended June 2026, while revenue came in above analysts’ expectations, according to a market report citing Moderna’s latest results.
THE APEX TIMES
THE APEX TIMES
The company reached an agreement to resolve about 76,000 lawsuits alleging its talc products caused ovarian cancer, with payments totaling as much as $5.5 billion.
THE APEX TIMES
The companies said the funding will support Resilience’s advanced manufacturing operations in Cincinnati, aiming to increase production of medicines for the U.S. market.
THE APEX TIMES
The Indianapolis-based drugmaker said it is increasing output for therapies used in diabetes and obesity, turning to a local manufacturer, Resilience, to add operating capacity in the Cincinnati area.
THE APEX TIMES
The health-care conglomerate said it has received U.S. Food and Drug Administration clearance for a surgical robot, while also continuing its long record of quarterly dividend hikes.
THE APEX TIMES
The company said the investment is expected to add at least 400 jobs and raise employment at its Resilience site in the state to more than 1,400, according to a report carried by Yahoo Finance.
THE APEX TIMES
An analyst’s underlying fair-value target for UnitedHealth Group moved higher following the company’s Q2 results, a shift that the market interpreted as an improvement in expectations.
THE APEX TIMES
A fresh cluster of European Commission approvals this week adds to the region’s evolving drug landscape, including updates affecting Pfizer’s and BioNTech’s vaccine portfolio and Incyte’s skin cancer and inflammatory pipeline.
THE APEX TIMES
The Woonsocket, Rhode Island-based health insurer and pharmacy retailer says its customer experience performance was recognized with an overall top honor plus four separate Gold Awards at the 2026 U.S. Customer Experience Awards.
